Iris Apatow, Edwin Ryding join ‘The Hunger Games: Sunrise on the Reaping’ cast
Phillip Faraone/VF25/Getty Images for Vanity Fair, Mike Marsland/WireImage via Getty Images
If you thought we were done with The Hunger Games: Sunrise on the Reaping cast announcements, think again.
Iris Apatow and Edvin Ryding are among the several new names joining the upcoming Lionsgate film’s ensemble cast.
Apatow will play Prosperina while Ryding will play Vitus in the film. Their characters are the two Capitol University students who are assigned to the District 12 tributes prep team.
Apatow is an actress and the daughter of Judd Apatow and Leslie Mann. Ryding is known for his starring role in the Netflix teen drama series Young Royals.
Also announced to be joining the film’s cast are Jax Guerrero and Sandra Förster as Tibby and Hersilia, respectively.
They all join a star-studded cast led by relative newcomer Joseph Zada as Haymitch Abernathy. Also part of the ensemble are Whitney Peak, Mckenna Grace, Glenn Close, Kieran Culkin, Elle Fanning, Ralph Fiennes, Kelvin Harrison Jr., Maya Hawke, Jesse Plemons, Billy Porter and Lili Taylor.
Francis Lawrence is directing the film adaptation of Suzanne Collins‘ novel from a screenplay by Billy Ray.
The Hunger Games: Sunrise on the Reaping arrives in theaters on Nov. 20, 2026.
Olivia Munn is opening up about her mom’s breast cancer diagnosis.
The Your Friends and Neighbors star, 45, took to Instagram on Wednesday and revealed that her mom was diagnosed with Stage 1 HER2 breast cancer after Munn’s own breast cancer diagnosis in 2023.
“Going through cancer is really hard,” Munn wrote in a statement shared in the post. “But there’s something about watching a loved one go through it that is even more heartbreaking.”
In the statement, Munn wrote that she “urged my mother and sister to take the Breast Cancer Lifetime Risk Assessment test” after receiving her diagnosis in 2023.
According to the Susan G. Komen foundation, the test is a tool “often used by health care providers to estimate breast cancer risk.”
Dr. Jennifer Ashton, former ABC News chief medical correspondent and a board-certified OB-GYN, said in a 2024 interview that the test “helps to provide an actual numerical risk for lifetime risk of breast cancer and breast cancer diagnosis in the next five years.”
“It is what we use in medicine to stratify a woman’s individual risk in a more precise way,” Ashton added.
According to the American College of Radiology, people with 20% or greater lifetime risk of breast cancer are considered high risk.
Munn said that her mother scored 26.2% on the IBIS, or the Tyrer-Cuzick Risk Assessment test, and because of that score, she wanted her mom to get an MRI, which led to learning about her Stage 1 HER2 breast cancer diagnosis.
The American Cancer Society describes HER2 as a “protein that helps breast cancer cells grow quickly.”
“Breast cancer cells with higher than normal levels of HER2 are called HER2-positive,” the ACS states. “These cancers tend to grow and spread faster than breast cancers that are HER2-negative, but are much more likely to respond to treatment with drugs that target the HER2 protein.”
Munn said her mom “completed 12 rounds of chemo” after her diagnosis “and will continue monthly Herceptin transfusions this fall.”
“I spent many nights taking care of my mom when the chemo became too much, wishing I could fight the fight for her, even if only for a day to give her a little break,” she continued. “It’s no small feat to realize you can’t do it for them. To anyone out there who is taking care of someone or has made it their profession to do so, thank you. These fights can feel near impossible without you.”
Munn said the Tyrer-Cuzick Risk Assessment “saved my life and now my mom’s.”
The Tyrer-Cuzick model, or IBIS, is a type of breast cancer risk calculator. According to the American College of Obstetricians and Gynecologists, this calculator is one of a few options that physicians can use to calculate lifetime risk of breast cancer.
“My mom wanted me to tell you that she hopes by sharing her story it will save someone’s life,” Munn said.
“I want to say how proud I am of my mom,” she added. “She’s handled all of this with bravery and humor while still driving us crazy (just days after her double mastectomy she tried to do laundry and make dinner — she’s insane).”
She thanked “the hospital nurses, patient coordinators and staff who have taken care of my mother,” as well as her mother’s primary care physician and oncologists, before thanking her own doctors as well.
Munn previously opened up about her private battle with breast cancer in a 2024 Instagram post. At the time, she revealed she had been diagnosed with Stage 1 aggressive Luminal B breast cancer in April 2023 and underwent a double mastectomy 30 days later.
Since then, Munn has been open about her experience, sharing her story to urge other women to get tested and to raise awareness about the disease.
“I’m lucky,” she said in her 2024 Instagram post about her diagnosis. “We caught it with enough time that I had options. I want the same for any woman who might have to face this one day.”
Devout fans of the Power universe who have tuned into the long-running Starz series may have heard of the character name Breeze. But now, more than 10 years and a few spinoff shows later, Breeze is finally getting a face to match his infamous name.
Spider-Verse star ShameikMoore will take on the role of Breeze, a drug kingpin from Jamaica, Queens, Starz announced Friday. He’s the newest addition to the season 5 cast of Power Book III: Raising Kanan, the third iteration in the Power series. The show chronicles the early years of Kanan Stark, a main character played by Curtis “50 Cent” Jackson in the original show.
“The Power Universe fans have been patiently anticipating this moment and I’m honored to step into the iconic role of Breeze,” Moore said. “I jumped into a story that is already alive with such strong characters, but it was a fun challenge to find Breeze’s unique identity, and I can’t wait for fans to see how Breeze will shift dynamics in the story. It’s gonna be a wild ride.”
“It was always my intention that Raising Kanan would run for five seasons, and … I’ve been able to tell the entirety of the story I set out to tell way back in 2019,” Sascha Penn, executive producer, writer and showrunner, said. “Having said that, with the table we’ve set in this season finale and the inevitable introduction of Breeze, there is still an exceptionally intense and action-packed season left for the viewers to experience.”
Moore will make his debut as Breeze during Friday night’s season 4 finale on Starz.
Jason Momoa says he did not help his son get cast in Dune: Part Three.
The actor, who starred as Duncan Idaho in Denis Villeneuve‘s 2021 film Dune, says he played no part in getting his son, Nakoa-Wolf Momoa, cast in the upcoming third film in the series.
Jason spoke to Extra about what Nakoa-Wolf can expect as part of the franchise.
“A rude awakening is what he’s in for,” Momoa said. “He’s into the workforce for the first time. It’s going to be good. He did it on his own. I don’t want to help him, and he’s done it all on his own, and good for him.”
Jason said as a parent, you “want your children to be better than you.”
“I really, actually believe he is,” Momoa said. “I couldn’t do what he’s doing at his age. There’s no way I could sit in a room with Denis Villeneuve and hold my own. I was on Baywatch at 19. He’s 16 and holding s*** down with Denis Villeneuve.”
Nakoa-Wolf, who is 16 years old, is the son of Jason Momoa and Lisa Bonet. Jason says the pair “raised him beautiful.”
“We raised our children. … It’s just, you know, being loved and being confident in themselves,” Momoa said. “That is what he is. He’s very confident.”
